Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Infection and CYP2B6[original query] |
|---|
| Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection. The Journal of antimicrobial chemotherapy 2010 Dec 65 (12): 2614-9. Jamshidi Y, Moreton M, McKeown D A, Andrews S, Nithiyananthan T, Tinworth L, Holt D W, Sadiq S |
| Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent. AIDS (London, England) 2011 Jun 25 (10): 1271-80. Yuan Jing, Guo Sheng, Hall David, Cammett Anna M, Jayadev Supriya, Distel Manuel, Storfer Stephen, Huang Zimei, Mootsikapun Piroon, Ruxrungtham Kiat, Podzamczer Daniel, Haas David W, |
| Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults. British journal of clinical pharmacology 2012 Dec 74 (6): 1005-12. Sukasem Chonlaphat, Cressey Tim R, Prapaithong Pattamawan, Tawon Yardpiroon, Pasomsub Ekawat, Srichunrusami Chutatip, Jantararoungtong Thawinee, Lallement Marc, Chantratita Was |
| Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes? Pharmacogenetics and genomics 2013 Nov 23 (11): 591-6. Micheli Janine E, Chinn Leslie W, Shugarts Sarah B, Patel Ashish, Martin Jeffrey N, Bangsberg David R, Kroetz Deanna |
| Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC infectious diseases 2013 13 261. Mukonzo Jackson K, Okwera Alphonse, Nakasujja Neoline, Luzze Henry, Sebuwufu Deogratious, Ogwal-Okeng Jasper, Waako Paul, Gustafsson Lars L, Aklillu Ele |
| Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. European journal of clinical pharmacology 2013 Nov 69 (11): 1909-16. Ciccacci Cinzia, Di Fusco Davide, Marazzi Maria C, Zimba Ines, Erba Fulvio, Novelli Giuseppe, Palombi Leonardo, Borgiani Paola, Liotta Giusep |
| High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections. Drug metabolism and pharmacokinetics 2013 28 (5): 391-7. Sukasem Chonlaphat, Chamnanphon Montri, Koomdee Napatrupron, Puangpetch Apichaya, Santon Siwalee, Jantararoungtong Thawinee, Prommas Santirat, Chantratita Wasun, Manosuthi Weeraw |
| Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti. The Journal of antimicrobial chemotherapy 2014 Aug 69 (8): 2187-90. Haas David W, Severe Patrice, Jean Juste Marc Antoine, Pape Jean William, Fitzgerald Daniel |
| Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes. The Journal of antimicrobial chemotherapy 2014 Aug 69 (8): 2175-82. Haas David W, Kwara Awewura, Richardson Danielle M, Baker Paxton, Papageorgiou Ioannis, Acosta Edward P, Morse Gene D, Court Michael |
| Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World journal of virology 2015 Aug 4 (3): 169-77. Asensi Victor, Collazos Julio, Valle-Garay Eulal |
| Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection. PloS one 2015 10 (6): e0130583. Meng Xianmin, Yin Kang, Wang Jiangrong, Dong Ping, Liu Li, Shen Yinzhong, Shen Li, Ma Qing, Lu Hongzhou, Cai Weim |
| CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study. Omics : a journal of integrative biology 2017 08 21 (8): 465-473. Reay Riaan, Dandara Collet, Viljoen Michelle, Rheeders Mal |
| Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Malaria journal 2017 07 16 (1): 267. Mutagonda Ritah F, Kamuhabwa Appolinary A R, Minzi Omary M S, Massawe Siriel N, Asghar Muhammad, Homann Manijeh V, Färnert Anna, Aklillu Ele |
| Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility. European journal of clinical pharmacology 2017 Jul . Ciccacci Cinzia, Latini Andrea, Politi Cristina, Mancinelli Sandro, Marazzi Maria C, Novelli Giuseppe, Palombi Leonardo, Borgiani Pao |
| Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin. European journal of clinical pharmacology 2018 7 74 (11): 1405-1415. Mugusi Sabina, Ngaimisi Eliford, Janabi Mohammed, Mugusi Ferdinand, Minzi Omary, Aris Eric, Bakari Muhammad, Bertilsson Leif, Burhenne Juergen, Sandstrom Eric, Aklillu Ele |
| A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine. The Journal of antimicrobial chemotherapy 2018 May . Ciccacci Cinzia, Politi Cristina, Mancinelli Sandro, Ciccacci Fausto, Lucaroni Francesca, Novelli Giuseppe, Marazzi Maria Cristina, Palombi Leonardo, Borgiani Pao |
| Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Mar . Kleinstein Sarah E, Shea Patrick R, Stamm Luisa M, Sulkowski Mark, Goldstein David B, Naggie Susan |
| Antiretroviral therapy immunologic non-response in a Brazilian population: association study using pharmaco- and immunogenetic markers. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 0 22 (5): 392-401. Coelho Antonio V C, Moura Ronald R de, Guimarães Rafael L, Brandão Lucas A C, Crovella Serg |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy. Clinical pharmacology and therapeutics 2019 4 106 (4): 726-733. Desta Zeruesenay, Gammal Roseann S, Gong Li, Whirl-Carrillo Michelle, Gaur Aditya H, Sukasem Chonlaphat, Hockings Jennifer, Myers Alan, Swart Marelize, Tyndale Rachel F, Masimirembwa Collen, Iwuchukwu Otito F, Chirwa Sanika, Lennox Jeffrey, Gaedigk Andrea, Klein Teri E, Haas David |
| Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019 Feb . Peko Simon Marie, Gueye Nerly Shirère Gampio, Vouvoungui Christevy, Koukouikila-Koussounda Félix, Kobawila Simon Charles, Nderu David, Velavan Thirumalaisamy P, Ntoumi Franci |
| Plasma efavirenz concentration inversely correlates with increased risk of cytomegalovirus infection in HIV-infected pregnant women. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2019 Dec 110 (1): 10-15. Mhandire D, Morse G, Maponga C, Mhandire K, Dandara |
| Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers. The pharmacogenomics journal 2019 Oct . Zubiaur Pablo, Saiz-Rodríguez Miriam, Ochoa Dolores, Belmonte Carmen, Román Manuel, Mejía Gina, Martín-Vilchez Samuel, Abad-Santos Francis |
| Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International journal of environmental research and public health 2019 Dec 17 (1): . Yu Ya-Yen, Tsao Shih-Ming, Yang Wen-Ta, Huang Wei-Chang, Lin Ching-Hsiung, Chen Wei-Wen, Yang Shun-Fa, Chiou Hui-Ling, Huang Yi-W |
| Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. Drug and alcohol dependence 2021 9 227 109025. Bart Gavin, Giang Le Minh, Yen Hoang, Hodges James S, Brundage Richard |
| Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2021 9 167 105986. Meng Xian-Min, Li Zi-Ran, Zheng Xin-Yin, Liu Yi-Xi, Niu Wan-Jie, Qiu Xiao-Yan, Lu Hong-Zh |
| Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2021 4 92 104856. Langaee Taimour, Al-Shaer Mohammad H, Gong Yan, Lima Elizabeth, Antwi Sampson, Enimil Anthony, Dompreh Albert, Yang Hongmei, Alghamdi Wael A, Wiesner Lubbe, Peloquin Charles A, Kwara Awewu |
| PharmVar GeneFocus: CYP2B6. Clinical pharmacology and therapeutics 2021 1 110 (1): 82-97. Desta Zeruesenay, El-Boraie Ahmed, Gong Li, Somogyi Andrew A, Lauschke Volker M, Dandara Collet, Klein Kathrin, Miller Neil A, Klein Teri E, Tyndale Rachel F, Whirl-Carrillo Michelle, Gaedigk Andr |
| Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity. Scientific reports 2022 Jun 12 (1): 9698. Petros Zelalem, Habtewold Abiy, Makonnen Eyasu, Aklillu Ele |
| Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022 Feb 14 (2): . Sendra Luis, Olivera Gladys G, López-Andújar Rafael, Serrano Cristina, Rojas Luis E, Montalvá Eva María, Herrero María José, Aliño Salvador |
| Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis. International journal of STD & AIDS 2022 11 34 (1): 37-47. Zhang Li, Meng Xianmin, Dong Ping, Qi Tangkai, Liu Li, Wang B |
- Page last reviewed:Feb 1, 2024
- Content source: